Workshop on co-morbidity data collection
Collecting data on co-morbidities in a clinically relevant way poses serious challenges. To begin to address this issue, and as part of the review of the National Cancer Dataset, NCIN held a workshop on co-morbidity data collection on 22nd October 2009.
Approximately 50 participants from NCIN's Site Specific Clinical Reference Groups (SSCRGs), representing a range of clinical specialties, cancer registries and other interested groups heard short lectures from a renowned international faculty and took part in two facilitated workshops to discuss the issues.
The aims of the day were to:
- To consider the need for routine co-morbidity data collection in all cancer patients
- To evaluate current methodologies
- To consider attributes of a generic tool
- To consider any site specific elements
- To consider feasibility of collection
A report summarising the discussions from the day is available here and the presentations are available below.
Presentations
| Title | Speaker |
|---|---|
| Introduction, the rationale and elements of co-morbidity | Mr Richard Wight |
| National Cancer Data Set Project | Di Riley | The American Experience | Dr Jay Piccirillo | The Dutch Experience | Dr Maryska Janssen-Heijnen | The Scottish Lung Experience | Dr Robert Milroy | DH & NHS CfH Co-morbidity Initiatives | Jayne Harding | The Value of HES for Co-morbidity Analyses | James Thomas | The Scottish Experience | Dr Diane Stockton |
| NCIN SSCRGs - current experience and site-specific needs | Dr Mick Peake |
